Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 February 2025 | Story Onthatile Tikoe | Photo Supplied
Shimlas 2024
The UFS Shimlas lifting the Varsity Cup on their home ground in Bloemfontein after their 2024 victory.

The highly anticipated Varsity Cup is finally here, and the University of the Free State (UFS) is buzzing with excitement! The tournament, which features the top university rugby teams in South Africa, promises to deliver thrilling matches and intense rivalries throughout the rugby season.

After an exhilarating 2024 season, the UFS Shimlas made history by lifting the Varsity Cup trophy on their home ground in Bloemfontein. The team’s impressive performance and dedication earned them a spot in the record books, and they are eager to repeat their success in 2025.

This year’s competition is scheduled to kick off on 17 February 2025 and will run for 7 weeks, with the UFS final game on 31 March 2025. The UFS Shimlas will be looking to defend their title and bring home the coveted trophy once again.

Previous winners

The Varsity Cup has a rich history, with previous winners including:

UFS Shimlas (2015, 2024)
Maties (Stellenbosch University, 2008-2010, 2019)
Tuks (University of Pretoria, 2012, 2013, 2017, 2021, 2022)
UCT Ikey Tigers (2011, 2014)

FNB NWU (2016, 2023)

UFS ready to take on the best

The UFS Shimlas have been preparing tirelessly for the tournament, with a strong focus on teamwork, discipline, and strategy. Head Coach André Tredoux expressed his excitement about the team’s prospects: “Being the defending champions comes with a bit of pressure, but we don’t see it that way. Our motto is that we want to attack the Varsity Cup, hence the best form of defence is to attack. The boys are really excited. They played well against UJ and scored lots of tries, hence our mindset is to attack everything we put our minds to.”

UFS Shimlas Team Captain Nkoka Ngobe echoed his coach’s sentiments, reinforcing his dedication to leading the team to victory. “As the team captain, I have to lead by example and bring the culture of excellence. I will never ask my teammates to do something that I cannot do, so the important thing for me is doing what it takes so that the boys can do the same.”

Get ready for the action

The Varsity Cup promises to deliver seven weeks of non-stop rugby action, with the UFS Shimlas ready to take on the best university teams in the country. Don’t miss out on the excitement – follow the UFS Shimlas on social media to stay up to date and get ready to cheer them on to victory!

Let’s go, Shimlas!

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept